Immune parameters to p67C antigen adjuvanted with ISA206VG correlate with protection against East Coast fever

Lacasta, Anna; Mwalimu, Stephen; Kibwana, Elisabeth; Saya, Rosemary; Awino, Elias; Njoroge, Thomas; Poole, Jane; Ndiwa, Nicholas N.; Pellé, Roger; Nene, Vishvanath; Steinaa, Lucilla

doi:10.1016/j.vaccine.2018.01.087

Cited by 11 publications

(24 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is in line with a previous study in mice, which used Ad5/MERS and boosted with spike protein nanoparticles and they found that balanced Ab and cell-mediated responses were generated (56). Importantly, in the current study, upon challenge, ∼53% of the cattle were immune to an approximately LD 93 sporozoite challenge, which is the highest challenge dose used to test p67C protective capacity and using more than three times less p67C Ag to date (7,10,11). ECF is a dose-dependent disease and the animals in the challenge experiment got double the amount of sporozoites compared with any of the previous published experiments (7,10,11), the immune response generated specifically against p67C had to fight a significantly higher parasite load to get 53% of the animals protected.…”

Section: Discussionsupporting

confidence: 90%

“…Twenty-one days after the last boost, all animals were given an s.c. syringe challenge of 1 ml of T. parva Muguga sporozoites (stabilate no. 3087), as previously described ( 11 ). After the challenge, all experimental cattle were monitored daily for changes in rectal temperatures and other clinical manifestations of ECF, and the ECF scores were calculated (Rowland index) ( 31 ).…”

Section: Methodsmentioning

confidence: 99%

“…Remarkably, an immunization regimen involving three inoculations of 450 μg of soluble p67C (s-p67C) Ag formulated in the Seppic adjuvant Montanide ISA 206 VG primes immunity to ECF in ∼50% of vaccinated cattle against an LD 70 sporozoite challenge ( 7 ), an efficacy level that is equivalent to that primed by p67 ( 7 , 10 ). However, reducing the number of inoculations of p67C to two resulted in immunity to ECF in only ∼25% of vaccinated cattle ( 11 ). Hence, an improved formulation of this polypeptide Ag is needed.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Synergistic Effect of Two Nanotechnologies Enhances the Protective Capacity of the Theileria parva Sporozoite p67C Antigen in Cattle

Lacasta

Mody

Goeyse

et al. 2021

The Journal of Immunology

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 90%

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Synergistic Effect of Two Nanotechnologies Enhances the Protective Capacity of the Theileria parva Sporozoite p67C Antigen in Cattle

Lacasta

Mody

Goeyse

et al. 2021

The Journal of Immunology

Self Cite

View full text Add to dashboard Cite

show abstract

“…Vaccination of cattle using a subunit vaccine based on the recombinant versions of p67 demonstrated a reduction in disease incidence by approximately 70% in the laboratory [30,31] and about 30% under field tick challenge [32]. Recent attempts have been made to improve the vaccination regimen by modifying the antigen preparation, dosage or adjuvant systems [33].…”

Section: Introductionmentioning

confidence: 99%

Analysis of p67 allelic sequences reveals a subtype of allele type 1 unique to buffalo-derived Theileria parva parasites from southern Africa

et al. 2020

View full text Add to dashboard Cite

East Coast fever (ECF) and Corridor disease (CD) caused by cattle-and buffalo-derived T. parva respectively are the most economically important tick-borne diseases of cattle in the affected African countries. The p67 gene has been evaluated as a recombinant subunit vaccine against ECF, and for discrimination of T. parva parasites causing ECF and Corridor disease. The p67 allele type 1 was first identified in cattle-derived T. parva parasites from East Africa, where parasites possessing this allele type have been associated with ECF. Subsequent characterization of buffalo-derived T. parva parasites from South Africa where ECF was eradicated, revealed the presence of a similar allele type, raising concerns as to whether or not allele type 1 from parasites from the two regions is identical. A 900 bp central fragment of the gene encoding p67 was PCR amplified from T. parva DNA extracted from blood collected from cattle and buffalo in South Africa, Mozambique, Kenya, Tanzania and Uganda, followed by DNA sequence analysis. Four p67 allele types previously described were identified. A subtype of p67 allele type 1 was identified in parasites from clinical cases of CD and buffalo from southern Africa. Notably, p67 allele type 1 sequences from parasites associated with ECF in East Africa and CD in Kenya were identical. Analysis of two p67 Bcell epitopes (TpM12 and AR22.7) revealed amino acid substitutions in allele type 1 from buffalo-derived T. parva parasites from southern Africa. However, both epitopes were conserved in allele type 1 from cattle-and buffalo-derived T. parva parasites from East Africa. These findings reveal detection of a subtype of p67 allele type 1 associated with T. parva parasites transmissible from buffalo to cattle in southern Africa.

show abstract

“…Vaccination of cattle using a subunit vaccine based on the recombinant versions of p67 demonstrated a reduction in disease incidence by approximately 70% in the laboratory (29, 30) and about 30% under field tick challenge (31). Recent attempts have been made to improve the vaccination regimen by modifying the antigen preparation, dosage or adjuvant systems (32).…”

Section: Introductionmentioning

confidence: 99%

Analysis of p67 allelic sequences reveals a subtype of allele type 1 unique to buffalo-derivedTheileria parvaparasites from southern Africa

Mukolwe

Odongo

Byaruhanga

et al. 2020

Preprint

View full text Add to dashboard Cite

28East Coast fever (ECF) and Corridor disease (CD) caused by cattle-and buffalo-derived 29 T. parva respectively are the most economically important tick-borne diseases of cattle in 30 the affected African countries. The p67 gene has been evaluated as a recombinant subunit 31 vaccine against East Coast fever (ECF), and for discrimination of T. parva parasites 32 causing ECF and Corridor disease (CD). The p67 allele type 1 was first identified in cattle-33 derived T. parva parasites from east Africa, where parasites possessing this allele type have 34 been associated with ECF. Subsequent characterization of buffalo-derived T. parva 35 parasites from South Africa where ECF was eradicated, revealed the presence of a similar 36 allele type, raising concerns as to whether or not allele type 1 from parasites from the two 37 regions is identical. A 900 bp central fragment of the gene encoding p67 was PCR 38 amplified from T. parva DNA extracted from blood collected from cattle and buffalo in 39 South Africa, Mozambique, Kenya, Tanzania and Uganda, followed by DNA sequence 40 analysis. Four p67 allele types previously described were identified. A subtype of p67 allele 41 type 1 was identified in parasites from clinical cases of CD and buffalo from southern 42 Africa. Notably, p67 allele type 1 sequences from parasites associated with ECF in East 43 Africa and CD in Kenya were identical. Analysis of two p67 B-cell epitopes (TpM12 and 44 AR22.7) revealed amino acid substitutions in allele type 1 from buffalo-derived T. parva 45 parasites from southern Africa. However, both epitopes were conserved in allele type 1 46 from cattle-and buffalo-derived T. parva parasites from East Africa. These findings reveal 47 detection of a subtype of p67 allele type 1 associated with T. parva parasites transmissible 48 from buffalo to cattle in southern Africa.49 50 3 51 Introduction 52 Theileriosis is a widespread tick-transmitted protozoal disease of wildlife and domestic 53 animals caused by an apicomplexan parasite of the genus Theileria (reviewed in 1). In 54 eastern, central and southern Africa, cattle theileriosis is commonly caused by Theileria 55 parva which occurs naturally in the African buffalo (Syncerus caffer) that is an asymptomatic 56 carrier (2). Theileria parva causes fatal classical East Coast fever (ECF) (3, 4), Corridor 57 disease (5, 6) and January disease (7) occurring in different African countries. This parasite 58 is mainly transmitted by a three-host brown ear tick Rhipicephalus appendiculatus, although 59Rhipicephalus zambeziensis and Rhipicephalus duttoni are also possible vectors (3, 8, 9). 60East Coast fever is estimated to result in an economic loss of about USD 300 due to death 61 of approximately one million cattle annually in the affected countries (reviewed in 1). A 62 live trivalent sporozoite vaccine for control of ECF was developed (10) and has been 63 successfully adopted for use in East Africa (11, 12). Although this vaccine does not confer 64 protection against buffalo-derived T. parva in Kenya (13...

show abstract

Immune parameters to p67C antigen adjuvanted with ISA206VG correlate with protection against East Coast fever

Abstract: HighlightsThree doses of p67C antigen generated stronger immune responses than two doses.Antibody titers and CD4+ T-cell proliferation correlated with protection against ECF.The number of doses could not be reduced from three to two without compromising the protection.

Cited by 11 publications

References 36 publications

Synergistic Effect of Two Nanotechnologies Enhances the Protective Capacity of the Theileria parva Sporozoite p67C Antigen in Cattle

Synergistic Effect of Two Nanotechnologies Enhances the Protective Capacity of the Theileria parva Sporozoite p67C Antigen in Cattle

Analysis of p67 allelic sequences reveals a subtype of allele type 1 unique to buffalo-derived Theileria parva parasites from southern Africa

Analysis of p67 allelic sequences reveals a subtype of allele type 1 unique to buffalo-derivedTheileria parvaparasites from southern Africa

Contact Info

Product

Resources

About